Joins us at booth n°1 - AMR conference
Body
We are thrilled to be exhibiting at the AMR Conference in Basel!
Our mission is to de-risk and accelerate the development of novel antimicrobials by providing robust preclinical infection models and tailored study designs.
On March 3–4, our CEO Maxime Fontanié and our CBO Robin Dumas will be at the Congress Center Basel to discuss:
Advanced in vitro and in vivo efficacy models for difficult-to-treat infections
Custom study designs for preclinical data packages
How we support biotech and pharma companies in their AMR pipelines
Come and meet us at Booth n°1 and let’s explore how we can support your next antimicrobial program.
👉 Join us at the AMR Conference
Image de la news
